387 research outputs found
Recommended from our members
Corrections to quark asymmetries at LEP
No full textThe most precise measurement of the weak mixing angle sin{sup 2} {theta}{sub eff}{sup l} at LEP is from the forward-backward asymmetry e{sup +}e{sup -} {yields} b{bar b} at the Z-pole. In this note the QED and electroweak radiative corrections to obtain the pole asymmetry from the measured asymmetry for b- and c-quarks have been calculated using ZFITTER, which has been amended to allow a consistent treatment of partial two-loop corrections for the b-quark final asymmetries. A total correction of {delta}A{sub FB}{sup b} = 0.0019 {+-} 0.0002 and {delta}A{sub FB}{sup c} = 0.0064 {+-} 0.0001 has been found, where the remaining theoretical uncertainty is much too small to explain the apparent discrepancy between sin{sup 2} {theta}{sub eff}{sup l} obtained from A{sub FB}{sup b} and from the left-right asymmetry at SLD
Measurement of inclusive K*0 (892), Phi (1020) and K(2)*0 (1430) production in hadronic Z decays
No full textThe inclusive production of the neutral vector mesons K*0(892) and φ(1020), and of the tensor meson K2*0(1430), in hadronic decays of the Z has been measured by the DELPHI detector at LEP. The average production rates per hadronic Z decay have been determined to be 0.77 ± 0.08 K*0(892), 0.104 ± 0.008 φ(1020) and 0.079 ± 0.040 K2*0(1430). The ratio of the tensor-to-vector meson production yields, 〈K2*0(1430)〉/〈K *0(892)〉 = 0.10± 0.05, is smaller than the 〈f2(1270)〉/〈ρ0(770)〉 and 〈f2′(1525)〉 /〈φ(1020)〉 ratios measured by DELPHI. The production rates and differential cross sections are compared with the predictions of JETSET 7.4 tuned to the DELPHI data and of HERWIG 5.8. The K*0(892) and φ(1020) data are compatible with model predictions, but a large disagreement is observed for the K2*0(1430)
Corrections to quark asymmetries at LEP
No full textThe most precise measurement of the weak mixing angle sin^2(theta) at LEP is from the forward-backward asymmetry e+e- --> bbbar at the Z-pole. In this note the QED and electroweak radiative corrections to obtain the pole asymmetry from the measured asymmetry for b- and c-quarks have been calculated using ZFITTER, which has been amended to allow a consistent treatment of partial two-loop corrections for the b-quark final asymmetries. A total correction of dAfbb=0.0019+/-0.0002 and dAfbc=0.0064+/-0.0001 has been found, where the remaining theoretical uncertainty is much too small to explain the apparent discrepancy between sin^2(theta) obtained from Afbb and from the left-right asymmetry at SLD
QCD corrections to the forward-backward asymmetries of and quarks at the Z pole
No full textMeasurements of the forward-backward production asymmetry of heavy quarks in Z decays provide a precise determination of \swsqeffl . The asymmetries are sensitive to QCD effects, in particular hard gluon radiation. In this paper QCD corrections for \AFBbb~ and \AFBcc~ are discussed. The interplay between the experimental techniques used to measure the asymmetries and the QCD effects is investigated using simulated events. A procedure to estimate the correction needed for experimental measurements is proposed, and some specific examples are given
Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)
No full textGastro-oEsophageal Cancers (GECs) are severe diseases whose management is rapidly evolving. The European Society of Surgical Oncology (ESSO) is committed to the generation and spread of knowledge, and promotes the multidisciplinary management of cancer patients through its core curriculum. The present work discusses the approach to GECs, including the management of oligometastatic oesophagogastric cancers (OMEC), the diagnosis and management of peritoneal metastases from gastric cancer (GC), the management of Siewert Type II tumors, the importance of mesogastric excision, the role of robotic surgery, textbook outcomes, organ preserving options, the use of molecular markers and immune check-point inhibitors in the management of patients with GECs, as well as the improvement of current clinical practice guidelines for the management of patients with GECs. The aim of the present review is to provide a concise overview of the state-of-the-art on the management of patients with GECs and, at the same time, to share the latest advancements in the field and to foster the debate between surgical oncologists treating GECs worldwide. We are sure that our work will, at the same time, give an update to the advanced surgical oncologists and help the training surgical oncologists to settle down the foundations for their future practice
- …
